F-box protein 22: A prognostic biomarker for colon cancer associated with immune infiltration and chemotherapy resistance

Figure 2 Gene alterations are associated with dysregulation of F-box protein 22 expression in colorectal cancer patients. A and B: The most common mutations described in human colon cancer specimen. Green lollipops indicate the somatic mutations described in human colon cancer. The analysis was performed using cBioPortal for Cancer Genomics; C-K: F-box protein 22 mRNA expression dysregulation associated with promoter methylation level in colon adenocarcinoma. FBXO22: F-box protein 22; TCGA: The Cancer Genome Atlas; COAD: Colon adenocarcinoma.